Self-renewal as a therapeutic target in human colorectal cancer

…, T Davis, L Cao, R Baiazitov, W Du, N Sydorenko… - Nature medicine, 2014 - nature.com
Tumor recurrence following treatment remains a major clinical challenge. Evidence from
xenograft models and human trials indicates selective enrichment of cancer-initiating cells (CICs…

[HTML][HTML] Small molecule splicing modifiers with systemic HTT-lowering activity

…, N Risher, S Yeh, Y Cheng, N Sydorenko… - Nature …, 2021 - nature.com
Huntington’s disease (HD) is a hereditary neurodegenerative disorder caused by expansion
of cytosine-adenine-guanine (CAG) trinucleotide repeats in the huntingtin (HTT) gene. …

A Formal [3+ 3] Cycloaddition Approach to Natural‐Product Synthesis

…, AV Kurdyumov, N Sydorenko - European journal of …, 2005 - Wiley Online Library
A formal [3 + 3] cycloaddition strategy for constructing complex heterocycles is reviewed here.
This formal cycloaddition involves condensation of α,β‐unsaturated iminium salts with 1,3‐…

BMI-1 targeting interferes with patient-derived tumor-initiating cell survival and tumor growth in prostate cancer

…, E Huselid, M Patrizii, D Jones, L Cao, N Sydorenko… - Clinical cancer …, 2016 - AACR
Purpose: Current prostate cancer management calls for identifying novel and more effective
therapies. Self-renewing tumor-initiating cells (TICs) hold intrinsic therapy resistance and …

Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression

…, O Kocher, P Zhang, YC Moon, N Sydorenko… - Science translational …, 2016 - science.org
Lung cancer is the most common cause of cancer deaths. The expression of the transcription
factor C/EBPα (CCAAT/enhancer binding protein α) is frequently lost in non–small cell lung …

Evaluating the mechanism and therapeutic potential of PTC-028, a novel inhibitor of BMI-1 function in ovarian cancer

…, SB Mustafi, P Mukherjee, L Cao, N Sydorenko… - Molecular cancer …, 2018 - AACR
BMI-1, also known as a stem cell factor, is frequently upregulated in several malignancies.
Elevated expression of BMI-1 correlates with poor prognosis and is therefore considered a …

A Lewis acid-catalyzed formal [3+ 3] cycloaddition of α, β-unsaturated aldehydes with 4-hydroxy-2-pyrone, diketones, and vinylogous esters

…, RP Hsung, GC Gullickson, KP Cole, N Sydorenko… - Organic …, 2006 - ACS Publications
Nadiya SydorenkoNadiya Sydorenko - Department of Chemistry, University of
Minnesota, Minneapolis, Minnesota 55455 … Cole, Nadiya Sydorenko, Jacob J. Swidorski …

A formal [3+ 3] cycloaddition reaction. 5. An enantioselective intramolecular formal aza-[3+ 3] cycloaddition reaction promoted by chiral amine salts

AI Gerasyuto, RP Hsung, N Sydorenko… - The Journal of Organic …, 2005 - ACS Publications
A detailed account on chiral secondary amine salt promoted enantioselective intramolecular
formal aza-[3 + 3] cycloadditions is described here for the first time. The dependence of …

Torquoselective 6π-Electron Electrocyclic Ring Closure of 1-Azatrienes Containing Acyclic Chirality at the C-Terminus

N Sydorenko, RP Hsung, EL Vera - Organic Letters, 2006 - ACS Publications
Nadiya SydorenkoNadiya Sydorenko - Division of Pharmaceutical Sciencies and
Department of Chemistry, Rennebohm Hall, 777 Highland Avenue, University of Wisconsin …

BMI1 is a therapeutic target in recurrent medulloblastoma

…, H Farooq, S Morrissy, L Cao, N Sydorenko… - Oncogene, 2019 - nature.com
Medulloblastoma (MB) is the most frequent malignant pediatric brain tumor, representing 20%
of newly diagnosed childhood central nervous system malignancies. Although advances …